University at Buffalo
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, University at Buffalo sits in the top decile of US sponsors by registered trial count (#312 of 15,742 sponsors by registered trial count).
University at Buffalo: 67 sponsored US clinical trials, none currently recruiting.
University at Buffalo sponsors 67 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 59 completed. 16 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Multiple Sclerosis, with 4 trials.
Top-decile sponsor footprint
University at Buffalo ranks in the top decile of sponsors by registered trial count (#312 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
59 of 66 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
67 total, page 2 of 2
Affect Recognition: Enhancing Performance of Persons With Acquired Brain Injury (ABI)
NCT00283153
The Suppression of Toll Like Receptors by Insulin
NCT01151605
Social Influences on Adolescents' Snack Purchases
NCT00875472
Exeantide in Type 2 Diabetes on Insulin
NCT01154933
The Effect of Januvia (Sitagliptin) on Oxidative Stress in Obese Type 2 Diabetic Subjects
NCT00659711
Kidney Biopsy Controlled Trial of Calcineurin Inhibitor Withdrawal
NCT00896012
Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) Study
NCT00937677
The Presence of Friends Increases Food Intake in Youth
NCT00874055
Peer Interactions and Food Are Substitutable in Youth
NCT00875121
Effects of Social Skills and Physical Activity Training on Recreational Activities in Youth
NCT00886171
Comparison of 1.5T vs. 3T Protocols After Treatment With Glatiramer Acetate (GA)
NCT00937157
Effect of Androgel on Atherogenesis in Type 2 Diabetic Males With Hypogonadotrophic Hypogonadism
NCT00467987
Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.
NCT00430040
Effect of Androgel on Type 2 Diabetic Males With Hypogonadism
NCT00350701
Venous Blood Flow Velocity: Electrical Foot Stimulation Compared to Intermittent Pneumatic Compression of the Foot
NCT00114608
Periodontitis and Cardiovascular Events or "PAVE"
NCT00066053
Effect of Pioglitazone on Oxidative Load, Inflammatory End-Points and Vascular Reactivity in Obese Non-Diabetic Patients: A Dose Ranging Study
NCT01161394
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
| Phase 3 | 6 |
| Phase 4 | 10 |
How the University at Buffalo archive is shaped
67 indexed studies, none listed as recruiting (0% open); 59 completed (88%).
Phase mix: 16 late (III/IV) vs 4 early (I/II) (later-stage heavy).
Top condition: Multiple Sclerosis (4 trials), 9 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
University at Buffalo: archived-pipeline peers nationwide
Peers matched on 67 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
University at Buffalo sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 67 archived trials
- Prisma Health-Upstate · 67 trials · 9% recruiting
- Vanda Pharmaceuticals · 68 trials · 22% recruiting
- Alkermes · 66 trials · 9% recruiting
- Cornell University · 66 trials · 15% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this University at Buffalo page
67 registered trials is a research-attention snapshot, not an endorsement of University at Buffalo or any single study.
- None of University at Buffalo's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Multiple Sclerosis is the condition University at Buffalo studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Sclerosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University at Buffalo pipeline card: 67 registered trials from official public datasets.Report a data error.